WHO asked to approve genetic engineering of smallpox virus for drug development

Scientists frustrated with the lack of progress toward a useful malaria vaccine may have edged a step closer to that goal with the announcement by a public-private partnership that it has created a promising candidate. GlaxoSmithKline's RTS,S/AS02A is a fusion of immunogenic components of the circumsporozoite protein with hepatitis B surface antigen, plus a proprietary adjuvant. The compound achieved a 58% efficacy against severe disease in 1- to 5-year-old children in a Phase IIb trial in Mozam

Trial offers evidence that an effective vaccine is feasible - but WHO expresses caution

Founder of farm animal biotechnology and creator of Tracy the transgenic sheep was 52

An effective product possible by the end of the decade, but $750m needed, researchers say

IAVI poised to create a consortium to study live attenuated AIDS vaccine in monkeys

Key US scientists missing from the increasingly political International AIDS Conference

Ministers call for 'decisive action,' while the chemical industry says WHO threatens business

Researcher files suit in Kenyan court against former colleagues studying HIV in children

Contract seen by some as a sign of developing countries move into research

A global program styled on the Human Genome Project gets the nod from world leaders

Scientific advisors call for international regime to regulate pathogen biocontainment